- βImproved diabetes-specific well-being was seen within just 13 weeks of starting the closed-loop pump
- βSignificant reductions in diabetes distress and fear of hypoglycaemia after 6 months of use
- βUsers felt they experienced fewer dangerously high blood sugar episodes, reducing a major source of daily anxiety
| Journal | BMJ open diabetes research & care |
| Year | 2024 |
| PMID | 39797667 |
What Was This Study About?
Researchers wanted to know whether using a hybrid closed-loop (HCL) insulin pump β a device that automatically adjusts insulin based on your glucose levels β could improve the emotional and psychological side of living with type 1 diabetes (T1D), not just blood sugar numbers.
How Was the Study Done?
120 adults with type 1 diabetes took part in a randomised controlled trial across multiple centres. Half used the MiniMed 670G hybrid closed-loop system for 26 weeks. The other half continued with their usual therapy β either an insulin pump or multiple daily injections β but without real-time continuous glucose monitoring.
Researchers measured several psychological outcomes at the start, middle (13 weeks), and end (26 weeks) of the trial, including:
- Diabetes-specific positive well-being
- Diabetes distress (emotional burden of managing diabetes)
- Fear of hypoglycaemia (low blood sugar)
- Treatment satisfaction
- Quality of life
What Did They Find?
People using the closed-loop pump experienced meaningful psychological benefits compared to those on standard therapy:
- Better well-being was seen as early as 13 weeks and lasted through the full 6 months.
- Less diabetes distress was reported at 26 weeks β meaning people felt less overwhelmed by managing their condition.
- Less fear of hypoglycaemia β users worried less about low blood sugar episodes and felt less need to keep glucose levels artificially high to avoid lows.
- Fewer perceived high glucose episodes β participants felt they were experiencing dangerously high blood sugar less often.
What Didn't Improve?
The closed-loop system did not significantly improve overall quality of life, treatment satisfaction, or awareness of hypoglycaemia symptoms compared to standard therapy. This suggests the technology's psychological benefits are specific rather than universal.
Why Does This Matter?
Managing type 1 diabetes is a 24/7 job that can take a serious toll on mental health. This study shows that beyond better glucose control, hybrid closed-loop technology can also ease the emotional burden β helping people feel more positive, less stressed, and less fearful about dangerous low blood sugars. If you are considering upgrading your diabetes technology, the mental health benefits may be just as important as the physical ones.